Correlation Between Pharmaceuticals Ultrasector and Small-cap Growth

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Small-cap Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Small-cap Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Small Cap Growth Profund, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Small-cap Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Small-cap Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Small-cap Growth.

Diversification Opportunities for Pharmaceuticals Ultrasector and Small-cap Growth

0.75

Correlation Coefficient

Pharmaceuticals Ultrasector  Small-cap Growth

Poor diversification

The 3 months correlation between Pharmaceuticals and Small-cap is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Small Cap Growth Profund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Small Cap Growth and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Small-cap Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Small Cap Growth has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Small-cap Growth go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Small-cap Growth

Assuming the 90 days horizon Pharmaceuticals Ultrasector is expected to generate 1.04 times less return on investment than Small-cap Growth. In addition to that, Pharmaceuticals Ultrasector is 1.82 times more volatile than Small Cap Growth Profund. It trades about 0.1 of its total potential returns per unit of risk. Small Cap Growth Profund is currently generating about 0.2 per unit of volatility. If you would invest  9,768  in Small Cap Growth Profund on April 24, 2025 and sell it today you would earn a total of  1,293  from holding Small Cap Growth Profund or generate 13.24% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Small Cap Growth Profund

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Small Cap Growth

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Small Cap Growth Profund are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Small-cap Growth showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmaceuticals Ultrasector and Small-cap Growth

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Small-cap Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Small-cap Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Small-cap Growth will offset losses from the drop in Small-cap Growth's long position.

The idea behind Pharmaceuticals Ultrasector Profund and Small Cap Growth Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.